This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We divided this population into 3 groups: (a) those with a diagnosis of CAA, (b) those with other cerebrovasculardisease without CAA, and (c) those without CAA or other cerebrovasculardisease. In pre-specified sensitivity analyses, patients with a diagnosis of dementia at baseline were excluded.Results:Among 8.5
Background:White matter hyperintensities (WMH) of presumed vascular origin can be associated with vascular cognitive impairment and dementia. Stroke, Volume 56, Issue Suppl_1 , Page ADP15-ADP15, February 1, 2025. However, WMH are also seen in asymptomatic subjects. FLAIR/T1 images were segmented to create WMH masks.
BackgroundBrain arterial diameters (BADs) are novel imaging biomarkers of cerebrovasculardisease, cognitive decline, and dementia. Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023.
Meschia is a pioneer in the study of inherited riskfactors for ischemic stroke and has had a longstanding commitment to providing the latest evidence for carotid revascularization as a means for stroke prevention. Meschia is certified by the American Board of Psychiatry and Neurology (ABPN) in neurology and vascular neurology.
Until then, I consider any of these to be independent adverse riskfactors. -- Finally, a dedicated syncope unit may improve evaluation and outcome (17). Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovasculardisease. to 0.81) for the external validation cohort.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content